New insight into how experiences and features of neurodiversity vary among UK adults

A new study has provided insight into how experiences and features of neurodiversity vary amongst adults in the UK.

Exploring ketamine’s potential in the fight against treatment-resistant depression

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

February 19, 2025

New model could help inform the risks and benefits of fish consumption during pregnancy

A new model developed by researchers could help inform guidelines and improve evidence-based advice on the risks and benefits of fish consumption, especially during pregnancy.

July 8, 2024

PhRMA renews pharmacy benefits manager campaign as Congressional scrutiny heats up

Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma

May 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.